FBIO

1.48

3.50% 0.05

Handel nachbörslich: 1.53 0.05 +3.38%

Fortress Biotech Inc (FBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FBIO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.43

Offen:

$1.46

24-Stunden-Volumen:

432.81K

Relative Volume:

0.76

Marktkapitalisierung:

$41.62M

Einnahmen:

$80.97M

Nettoeinkommen (Verlust:

$-78.31M

KGV:

-0.0997

EPS:

-14.85

Netto-Cashflow:

$-129.56M

1W Leistung:

-15.91%

1M Leistung:

-19.13%

6M Leistung:

-23.32%

1J Leistung:

-29.19%

1-Tages-Spanne:

$1.455

$1.54

1-Wochen-Bereich:

$1.41

$1.75

52-Wochen-Spanne:

$1.355

$4.43

Fortress Biotech Inc Stock (FBIO) Company Profile

Firmenname

Fortress Biotech Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

781-652-4500

Adresse

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Mitarbeiter

186

Twitter

@fortressbio

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

FBIO's Discussions on Twitter

Vergleichen Sie FBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FBIO	1.48	41.62M	80.97M	-78.31M	-129.56M	-14.85
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-15	Fortgesetzt	ROTH MKM	Buy
2022-08-04	Eingeleitet	Ladenburg Thalmann	Buy
2020-10-02	Eingeleitet	The Benchmark Company	Buy
2019-12-18	Eingeleitet	B. Riley FBR	Buy
2018-02-28	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-07-11	Eingeleitet	Rodman & Renshaw	Buy
2017-03-22	Eingeleitet	JMP Securities	Mkt Outperform
2016-10-03	Eingeleitet	ROTH Capital	Buy

Alle ansehen

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

11:01 AM

Fortress Biotech price target lowered to $4 from $5 at Alliance Global Partners - TipRanks

11:01 AM

07:44 AM

Fortress Biotech price target raised to $26 from $24 at H.C. Wainwright - TipRanks

07:44 AM

07:41 AM

Fortress Biotech (FRA:CNB1) Total Inventories : €9.00 Mil (As of Jun. 2024) - GuruFocus.com

07:41 AM

Nov 17, 2024

Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

Fortress Biotech Q3 2024 Earnings: EPS Loss of $0.76 Beats Estimate, Revenue of $14.63M Misses Expectations - GuruFocus.com

Nov 14, 2024

Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024

Avenue Therapeutics Reports $3.1M Q3 Loss, Advances Key Clinical Trials Pipeline | ATXI Stock News - StockTitan

Nov 14, 2024

Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Nov 12, 2024

Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss | FBIO Stock News - StockTitan

Nov 12, 2024

Journey Medical's Mixed Q3: FDA Win for Rosacea Drug Despite Revenue Dip | FBIO Stock News - StockTitan

Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024

Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan

Nov 12, 2024

Where are the Opportunities in (FBIOP) - Stock Traders Daily

Nov 12, 2024

Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India

Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK

Nov 07, 2024

Nov 01, 2024

How To Trade (FBIOP) - Stock Traders Daily

Nov 01, 2024

Oct 31, 2024

Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m - Yahoo Finance

Oct 31, 2024

Oct 30, 2024

Biotech Stocks Facing FDA Decision In November 2024 - RTTNews

Oct 30, 2024

Oct 29, 2024

Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 36% But Its Business Still Trails The Industry - Simply Wall St

Oct 29, 2024

Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares - Yahoo Finance

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortres - GuruFocus.com

Oct 25, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewswire

Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024

Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - The Manila Times

Oct 24, 2024

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - The Manila Times

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024

Oct 07, 2024

Analysts review Fortress Biotech Inc’s rating - Knox Daily

Oct 07, 2024

Was there any good news for Fortress Biotech Inc (FBIO) stock in the last session? - US Post News

Oct 07, 2024

Oct 03, 2024

PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD acquire 763,359 shares of Fortress Biotech Inc [FBIO] - Knox Daily

Oct 03, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire

Oct 03, 2024

Oct 02, 2024